The goal of the project is to use the understanding of CD33 function to design novel therapeutic strategies for enhancing clearance of the aggregation-prone amyloid beta peptide in Alzheimer's disease.
Base: $20.16 - $29.01/Hourly; Bonus/Equity: Not specified; Benefits: Comprehensive benefits package
Must-have
Nice-to-have
Not specified